The thrust of the allegations against Health Net are (1) that it provides coverage and payment for Hikma’s generic product even in cases where Health Net actually knows that a particular beneficiary is using the generic version for an unapproved—and allegedly infringing— CV use, and (2) that Health Net actually encourages use of Hikma’s product instead of Vascepa for the CV use because Health Net requires its beneficiaries to pay a higher copay for Vascepa than for Hikma’s generic version
So when does the judge confirm the magistrate's opinion, or is this now a done deal? At least she made it clear she understands AMRN's complaint against HN - their PA shows they know exactly who is getting GV for an infringing use - they are actively encouraging infringement.